An Open-Label, Sequential-Design Drug Interaction Study of the Effects of Omeprazole on the Pharmacokinetics of Ibrutinib in Healthy Adults
Study of the effect of CYP2C19 polymorphisms on omeprazole pharmacokinetics by utilizing validated LC–MS/MS and Real Time-PCR methods
Tags: CYP2C19 enzyme inhibitor, CYP3A4 enzyme inhibitor, gastroesophageal reflux, irreversible proton pump inhibitor, Losec®, peptic ulcer, Prilosec®, Zollinger-Ellison syndrome
BASi Method Number SAP.930
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
